Mesenchymal stem cells derived from human exfoliated deciduous teeth (SHEDs) induce immune modulatory profile in monocyte-derived dendritic cells

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  De Sá Silva, Fernando ^a,c   Ramos, Rodrigo Nalio ^a   De Almeida, Danilo Candido ^a   Bassi, Enio Jose ^a   Gonzales, Roberto Pereira ^a   Miyagi, Sueli Patricia Harumi ^a   Maranduba, Claudinéia Pereira ^c   Sant'Anna, Osvaldo Augusto Brazil Esteves ^c   Marques, Márcia Martins ^b   Barbuto, José Alexandre Marzagão ^a   Câmara, Niels Olsen Saraiva ^a   Da Costa Maranduba, Carlos Magno ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

^c University of Juiz de Fora   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD1C ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 2; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; COCULTURE; CONTROLLED STUDY; DECIDUOUS TOOTH; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; MONOCYTE DERIVED DENDRITIC CELL; T LYMPHOCYTE ACTIVATION;

EID: 84901342318     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098050     Document Type: Article

References (31)

1. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, et al. (2002) Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30: 42-48. (Pubitemid 34059216)
2. Krampera M, Sartoris S, Liotta F, Pasini A, Angeli R, et al. (2007) Immune regulation by mesenchymal stem cells derived from adult spleen and thymus. Stem Cells Dev 16: 797-810. (Pubitemid 350125228)
3. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringdén O (2003) Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57: 11-20. (Pubitemid 38019084)
4. Zhang W, Ge W, Li C, You S, Liao L, et al. (2004) Effects of mesenchy-mal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev13: 263-271. (Pubitemid 38738368)
5. Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105: 1815-1822. (Pubitemid 40223708)
6. Bassi EJ, Moraes-Vieira PM, Moreira-Sá CS, Almeida DC, Vieira LM, etal. (2012) Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes. Diabetes 61: 2534-2545.
7. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringdén O (2003) HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31: 890-896. (Pubitemid 37211373)
8. Yagi H, Soto-Gutierrez A, Parekkadan B, Kitagawa Y, Tompkins RG, et al. (2010) Mesenchymal Stem Cells: Mechanisms of Immunomodulation and Homing. Cell Transplant 19: 667-679.
9. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, et al. (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228. (Pubitemid 32295155)
10. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S (2000) Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA 97: 13625-13630.
11. Pierdomenico L, Bonsi L, Calvitti M, Rondelli D, Arpinati M, et al. (2005) Multipotent Mesenchymal Stem Cells with Immunosuppressive Activity Can Be Easily Isolated from Dental Pulp. Transplantation 80: 836-842. (Pubitemid 41443768)
12. Yamaza T, Kentaro A, Chen C, Liu Y, Shi Y, et al. (2010) Immunomodulatory properties of stem cells from human exfoliated deciduous teeth. Stem Cell Research & Therapy 1: 1-10.
13. Alipour R, Adib M, Masoumi Karimi M, Hashemi-Beni B, Sereshki N. (2013) Comparing the immunoregulatory effects of stem cells from human exfoliated deciduous teeth and bone marrow-derived mesenchymal stem cells. Iran J Allergy Asthma Immunol 12: 331-344.
14. Lai HY, Yang MJ, Wen KC, Chao KC, Shih CC, et al. (2010) Mesenchymal Stem Cells Negatively Regulate Dendritic Lineage Commitment of Umbilical-Cord-Blood- Derived Hematopoietic Stem Cells: An Unappreciated Mechanism as Immunomodulators. Tissue Engineering: Part A 16: 2987-2997.
15. Oliveira BL, Cavalcanti CM, Azevedo ANS, Tomiyoshi MY, Bergami-Santos PC et al. (2009) Human monocytes but not dendritic cells are killed by blocking of autocrine cyclooxygenase activity. Cellular Immunology 258: 107-114.
16. Ramos RN, Chin LS, Dos Santos AP, Bergami-Santos PC, Laginha F, et al. (2012) Monocyte-derived dendritic cells from breast cancer patients are biased to induce CD4+CD25+Foxp3+ regulatory T cells. J Leukoc Biol 92: 673-682.
17. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147. (Pubitemid 29282067)
18. Ferrari D, La Sala A, Chiozzi P, Morelli A, Falzoni S, et al. (2000) The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release. FASEB J 14: 2466-2476.
19. Angelot F, Seillès E, Biichlé S, Berda Y, Gaugler B, et al. (2009) Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases. Haematologica 94: 1502-1512.
20. Choi YS, Jeong JA, Lim DS (2012) Mesenchymal stem cell-mediated immature dendritic cells induce regulatory T cell-based immunosuppressive effect. Immunol Invest 41: 214-229.
21. Kota DJ, Wiggins LL, Yoon N, Lee RH (2013) TSG-6 produced by hMSCs delays the onset of autoimmune diabetes by suppressing Th1 development and enhancing tolerogenicity. Diabetes 62: 2048-2058.
22. Zhao ZG, Xu W, Sun L, You Y, Li F, et al. (2012) Immunomodulatory function of regulatory dendritic cells induced by mesenchymal stem cells. Immunol Invest 41: 183-198.
23. English K, Ryan JM, Tobin L, Murphy MJ, Barry FP, et al. (2009) Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. Clin Exp Immunol 156: 149-160.
24. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, et al. (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742. (Pubitemid 27458961)
25. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK (2001) Type 1 T regulatory cells. Immunol Rev 182: 68-79. (Pubitemid 33070208)
26. Beissert S, Schwarz A, Schwarz T (2006) Regulatory T cells. J Invest Dermatol 126: 15-24. (Pubitemid 43336089)
27. Couper KN, Blount DG, Riley EM (2008) IL-10: The Master Regulator of Immunity to infection. J Immunol 180: 5771-5777.
28. Chaudhry A, Samstein RM, Treuting P, Liang Y, Pils MC, et al. (2011) Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34: 566-578.
29. Oldenhove G, Bouladoux N, Wohlfert EA, Hall JA, Chou D, et al. (2009) Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31: 772-786.
30. Ryan JM, Barry F, Murphy JM, Mahon BP (2007) Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 149: 353-363. (Pubitemid 47063057)
31. Silva FS, Almeida PN, Rettore JV, Maranduba CP, de Souza CM, et al. (2012) Toward Personalized Cell Therapies by Using Stem Cells: Seven Relevant Topics for Safety and Success in Stem Cell Therapy. J Biomed Biotechnol doi: 10.1155/2012/758102.